Colon Cancer Home > Erbitux and Lung Cancer

The U.S. Food and Drug Administration (FDA) has approved Erbitux® (cetuximab) for the treatment of squamous cell carcinoma of the head and neck, as well as certain types of advanced cancer affecting the colon or rectum. At times, drugs are used for conditions they are not approved to treat. This is called an off-label use. Using Erbitux for non-small cell lung cancer is an example of this.
(Click Erbitux Uses for more information on possible off-label uses, when this drug is prescribed, and whether it can be given to children and older adults.)
Written by/reviewed by:
Last reviewed by: Kristi Monson, PharmD;
Last updated/reviewed:
List of references (click here):
Topics & Medications


Related Channels

eMedTV Links
Copyright © 2006-2019 Clinaero, Inc.

eMedTV serves only as an informational resource. This site does not dispense medical advice or advice of any kind. Site users seeking medical advice about their specific situation should consult with their own physician. Click Terms of Use for more information.

This site complies with the HONcode standard for trustworthy health information:
verify here.